Cas no 1023814-02-9 (5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile)
5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile Chemical and Physical Properties
Names and Identifiers
-
- 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile
-
- Inchi: 1S/C6H4BrN3O2S/c1-13(11,12)6-9-3-4(7)5(2-8)10-6/h3H,1H3
- InChI Key: MMFDKYSVUXQWJB-UHFFFAOYSA-N
- SMILES: C1(S(C)(=O)=O)=NC=C(Br)C(C#N)=N1
5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM484414-1g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 97% | 1g |
$613 | 2023-02-27 | |
| Ambeed | A432515-10g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 97% | 10g |
$2388.0 | 2024-04-26 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1657532-1g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 98% | 1g |
¥9084 | 2023-04-17 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1657532-5g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 98% | 5g |
¥16125 | 2023-04-17 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1657532-10g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 98% | 10g |
¥22477 | 2023-04-17 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD605782-1g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 97% | 1g |
¥4291.0 | 2023-02-27 | |
| Ambeed | A432515-1g |
5-Bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile |
1023814-02-9 | 97% | 1g |
$625.0 | 2023-03-02 |
5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile Related Literature
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
Additional information on 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile
Introduction to 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile (CAS No. 1023814-02-9)
5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile, with the CAS number 1023814-02-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the pyrimidine class, which is well-known for its diverse biological activities and applications in drug development. The presence of both bromine and a methylsulfonyl group in its structure imparts unique reactivity, making it a valuable intermediate in synthetic chemistry.
The structural features of 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile make it a versatile building block for the synthesis of more complex molecules. The bromine atom at the 5-position provides a handle for further functionalization via cross-coupling reactions, while the methylsulfonyl group at the 2-position enhances its solubility and reactivity in various chemical transformations. These properties have positioned this compound as a key intermediate in the development of novel therapeutic agents.
In recent years, there has been a surge in research focused on developing new methodologies for the synthesis of heterocyclic compounds, particularly pyrimidines. The demand for efficient and scalable synthetic routes has led to the exploration of novel reagents and catalysts. 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile has emerged as a critical component in several synthetic strategies due to its ability to undergo multiple transformations while maintaining structural integrity.
One of the most notable applications of 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile is in the synthesis of biologically active pyrimidine derivatives. These derivatives have shown promise in various therapeutic areas, including oncology, antiviral, and anti-inflammatory treatments. The compound's ability to serve as a precursor for these derivatives is largely attributed to its reactive sites, which can be selectively modified to introduce additional functional groups.
The pharmaceutical industry has been particularly interested in leveraging the reactivity of 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile to develop new drug candidates. For instance, researchers have utilized this compound to synthesize pyrimidine-based kinase inhibitors, which are known for their effectiveness in targeting specific cancer pathways. The bromine moiety allows for palladium-catalyzed cross-coupling reactions, enabling the introduction of aryl or heteroaryl groups at various positions within the pyrimidine core.
The role of methylsulfonyl groups in enhancing the pharmacological properties of pyrimidine derivatives cannot be overstated. These groups not only improve solubility but also contribute to metabolic stability, making them ideal for drug development. The incorporation of such functionalities has been shown to enhance binding affinity and selectivity, thereby improving overall therapeutic efficacy.
In addition to its pharmaceutical applications, 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile has found utility in agrochemical research. Pyrimidine-based compounds are widely used as herbicides and fungicides due to their ability to disrupt essential biological processes in pests and weeds. The structural versatility of this compound allows researchers to design derivatives with enhanced activity against resistant strains, ensuring sustainable agricultural practices.
The synthesis of 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile typically involves multi-step organic reactions that require careful optimization to ensure high yields and purity. Recent advancements in synthetic methodologies have enabled more efficient production processes, reducing costs and environmental impact. These improvements are crucial for meeting the growing demand for high-quality intermediates in industrial applications.
The use of computational tools and high-throughput screening has further accelerated the discovery and development of novel pyrimidine derivatives derived from 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile. These approaches allow researchers to rapidly evaluate the potential biological activity of different derivatives, facilitating the identification of lead compounds for further optimization.
In conclusion, 5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile (CAS No. 1023814-02-9) is a highly valuable intermediate with broad applications in pharmaceutical and agrochemical research. Its unique structural features enable diverse synthetic transformations, making it an indispensable tool for chemists developing new therapeutic agents and crop protection products. As research continues to evolve, this compound is expected to play an even greater role in advancing drug discovery and sustainable agriculture.
1023814-02-9 (5-bromo-2-(methylsulfonyl)pyrimidine-4-carbonitrile) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)